• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form 8-A12B filed by Swiftmerge Acquisition Corp.

    12/13/24 4:45:49 PM ET
    $IVCP
    Blank Checks
    Finance
    Get the next $IVCP alert in real time by email
    8-A12B 1 ea0224492-8a12b_aleanna.htm FOR REGISTRATION OF CERTAIN CLASSES

     

     

    UNITED STATES
    SECURITIES AND EXCHANGE COMMISSION

    Washington, D.C. 20549

     

     

     

    FORM 8-A

     

     

     

    FOR REGISTRATION OF CERTAIN CLASSES OF SECURITIES

    PURSUANT TO SECTION 12(b) OR (g) OF

    THE SECURITIES EXCHANGE ACT OF 1934

     

     

     

    AleAnna, Inc.

    (Exact Name of Registrant as Specified in Its Charter)

     

     

     

    Delaware   98-1582153
    (State or other jurisdiction of
    incorporation or organization)
      (I.R.S. Employer
    Identification No.)

     

    300 Crescent Court, Suite 1860

    Dallas, Texas

      75201
    (Address of principal executive offices)   (Zip Code)

     

    Securities to be registered pursuant to Section 12(b) of the Act:

     

    Title of each class

    to be registered

     

    Name of each exchange on which

    each class is to be registered

    Class A common stock, par value $0.0001 per share   The Nasdaq Stock Market LLC
    Warrants, each whole warrant exercisable for one share of Class A common stock   The Nasdaq Stock Market LLC

     

    If this form relates to the registration of a class of securities pursuant to Section 12(b) of the Exchange Act and is effective pursuant to General Instruction A.(c) or (e), check the following box. ☒

     

    If this form relates to the registration of a class of securities pursuant to Section 12(g) of the Exchange Act and is effective pursuant to General Instruction A.(d) or (e), check the following box. ☐

     

    If this form relates to the registration of a class of securities concurrently with a Regulation A offering, check the following box. ☐

     

    Securities Act registration statement or Regulation A offering statement file number to which this form relates: 333-280699 (if applicable)

     

    Securities to be registered pursuant to Section 12(g) of the Act: None

     

     

     

     

     

     

    Item 1. Description of Registrant’s Securities to be Registered.

     

    The securities to be registered hereby are (i) the shares of Class A common stock, par value $0.0001 per share (the “Class A Common Stock”) of AleAnna, Inc., a Delaware corporation (f/k/a Swiftmerge Acquisition Corp.) (the “Company”) and (ii) warrants to purchase shares of Class A Common Stock (the “Warrants”) of the Company. The description of the Class A Common Stock and the Warrants set forth under the heading “Description of Securities of the Surviving PubCo’s Securities” in the final prospectus and definitive proxy statement, dated November 21, 2024, filed with the Securities and Exchange Commission (the “SEC”) on November 21, 2024 and forming a part of the Company’s registration statement on Form S-4 originally filed with the SEC on July 5, 2024, as amended, (File No. 333-280699) (the “Registration Statement”) to which this Form 8-A relates, is incorporated by reference. Any form of prospectus or prospectus supplement to the Registration Statement that includes such descriptions and that are subsequently filed are hereby also incorporated by reference herein.

     

    Item 2. Exhibits.

     

    In accordance with the “Instructions as to Exhibits” with respect to Form 8-A, no exhibits are required to be filed as part of this registration statement because no other securities of the registrant are registered on The Nasdaq Capital Market and the securities registered hereby are not being registered pursuant to Section 12(g) of the Securities Exchange Act of 1934, as amended. 

     

    1

     

     

    SIGNATURES

     

    Pursuant to the requirements of Section 12 of the Securities Exchange Act of 1934, the registrant has duly caused this registration statement to be signed on its behalf by the undersigned, thereto duly authorized.

     

    Date: December 13, 2024

     

      ALEANNA, INC.
         
      By: /s/ Tristan Yopp
      Name: Tristan Yopp
      Title: Chief Financial Officer

     

    2

     

    Get the next $IVCP alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $IVCP

    DatePrice TargetRatingAnalyst
    More analyst ratings

    $IVCP
    SEC Filings

    View All

    SEC Form CERT filed by Swiftmerge Acquisition Corp.

    CERT - AleAnna, Inc. (0001845123) (Filer)

    12/13/24 5:25:53 PM ET
    $IVCP
    Blank Checks
    Finance

    SEC Form 15-12G filed by Swiftmerge Acquisition Corp.

    15-12G - AleAnna, Inc. (0001845123) (Filer)

    12/13/24 5:23:00 PM ET
    $IVCP
    Blank Checks
    Finance

    SEC Form 8-A12B filed by Swiftmerge Acquisition Corp.

    8-A12B - AleAnna, Inc. (0001845123) (Filer)

    12/13/24 4:45:49 PM ET
    $IVCP
    Blank Checks
    Finance

    $IVCP
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 4 filed by Former CEO Bremner John

    4 - AleAnna, Inc. (0001845123) (Issuer)

    12/17/24 5:15:08 PM ET
    $IVCP
    Blank Checks
    Finance

    SEC Form 4 filed by Director Jones George L

    4 - AleAnna, Inc. (0001845123) (Issuer)

    12/17/24 5:15:06 PM ET
    $IVCP
    Blank Checks
    Finance

    Large owner Swiftmerge Holdings, Lp disposed of 2,706,012 shares (SEC Form 4)

    4 - AleAnna, Inc. (0001845123) (Issuer)

    12/17/24 5:15:05 PM ET
    $IVCP
    Blank Checks
    Finance

    $IVCP
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    AleAnna, Inc. Announces Completion of Business Combination between Swiftmerge Acquisition Corp. and AleAnna Energy, LLC

    Combination brings emerging leader in Italian natural gas and renewable natural gas to public marketsShares of AleAnna, Inc. to begin trading on Nasdaq on December 16 under the ticker symbol "ANNA"AleAnna stands on the cusp of a major milestone, with the first phase of natural gas production from the Longanesi Field projected to commence in Q1 2025 DALLAS and VANCOUVER, British Columbia and ROME, Dec. 13, 2024 (GLOBE NEWSWIRE) -- AleAnna, Inc. (together with its subsidiaries, "AleAnna" or the "Company"), an emerging leader in Italy's energy landscape, announced the completion of the previously announced business combination (the "Business Combination") between Swiftmerge Acquisition Corp.

    12/13/24 4:05:24 PM ET
    $IVCP
    Blank Checks
    Finance

    HDL Therapeutics to Go Public in Merger with Swiftmerge Acquisition Corp.

    $480 million Business Combination to Accelerate the Commercialization of an Innovative FDA-Approved Cardiovascular Disease Treatment HDL Therapeutics, Inc. ("HDL Therapeutics"), a privately held commercial stage biotech company with an FDA-approved cardiovascular therapy the Plasma Delipidation System (PDS-2™ System) for reducing coronary atheroma in patients with homozygous familial hypercholesterolemia (HoFH), has signed a definitive merger agreement with Swiftmerge Acquisition Corp. (NASDAQ:IVCP) ("Swiftmerge"), a special purpose acquisition company with a disruptive consumer healthcare focused team. Under the terms of the merger agreement, a wholly-owned subsidiary of Swiftmerge will

    8/11/23 1:54:00 PM ET
    $IVCP
    Blank Checks
    Finance

    HDL Therapeutics Inc Plans to Become Publicly Traded via a Business Combination With $225 Million Swiftmerge (NASDAQ: IVCP) With Goal to Transform Cardiovascular Disease Treatment

    NASDAQ IVCP Swiftmerge Acquisition Corp ("Swiftmerge"), a $225 million innovative healthcare investment corporation and a special purpose acquisition company, announced today the signing of a non-binding letter of intent ("LOI") for a business combination with HDL Therapeutics Inc. ("HDL Therapeutics"), a privately held commercial stage biotech company with an FDA-approved cardiovascular therapy for reducing coronary atheroma in homozygous familial hypercholesterolemia (HoFH) patients. HDL Therapeutics' platform, removes the highest risk plaques in coronary arteries that tend to rupture causing heart attacks and stroke. HDL expects this platform to have significant implications in the futur

    4/24/23 1:31:00 PM ET
    $IVCP
    Blank Checks
    Finance

    $IVCP
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by Swiftmerge Acquisition Corp.

    SC 13G/A - Swiftmerge Acquisition Corp. (0001845123) (Subject)

    12/6/24 4:22:36 PM ET
    $IVCP
    Blank Checks
    Finance

    Amendment: SEC Form SC 13G/A filed by Swiftmerge Acquisition Corp.

    SC 13G/A - Swiftmerge Acquisition Corp. (0001845123) (Subject)

    11/14/24 2:43:56 PM ET
    $IVCP
    Blank Checks
    Finance

    Amendment: SEC Form SC 13G/A filed by Swiftmerge Acquisition Corp.

    SC 13G/A - Swiftmerge Acquisition Corp. (0001845123) (Subject)

    11/14/24 1:56:08 PM ET
    $IVCP
    Blank Checks
    Finance